In the previous report, we disclosed that a-truxillic acid (1) and its derivative 4,4Ј-dihydroxy-a-truxillic acid (2) showed significant anti-inflammatory activities in the formalin test. Their monomer components (E)-cinnamic acid and (E)-p-coumaric acid exhibited only weak or no activity. 1) This result suggested that the dimeric structure played an important role in the expression of anti-inflammatory activity. In the course of our investigation of antinociceptive substances from natural sources, a novel monoterpene alkaloid, incarvillateine, was characterized from a traditional Chinese crude drug designed as 'Tougucao' (Incarvillea sinensis).
Antinociceptive Activities of a a-Truxillic Acid and b b-Truxinic Acid Derivatives
were allowed food and water ad libitum and they were housed in an air-conditioned room maintained at 22Ϯ2°C with a humidity of 55Ϯ5%. The experimental animals were allocated randomly into groups.
Chemicals (E )-p-Coumaric acid, 4-chlorocinnamic acid, 3-(3-pyridyl)acrylic acid, p-nitrophenol, cinnamyl chloride, N,N-dimethylformamide, trimethylsilyldiazomethane were purchased from Tokyo Kasei (Tokyo, Japan). Thionyl chloride and lithium aluminium hydride (LiAlH 4 ) were bought from Kanto Kagaku (Tokyo, Japan). (E)-Cinnamic acid and Tween 80 (polyoxyethylene sorbitan monooleate) were purchased from Nacalai Tesque (Kyoto, Japan). Ringer solution was obtained from Fuso Pharmaceutical (Osaka, Japan).
General Methods Melting points were uncorrected. IR spectra were recorded on a Hitachi 270-30 spectrometer.
1 Hand 13 C-NMR spectra were obtained with a JEOL a-500 spectrometer, and chemical shifts were given on a d (ppm) scale with tetramethylsilane as an internal standard. The EI-MS and FAB-MS were measured with a JOEL DX-303 HF spectrometer. TLC was performed on precoated Kieselgel 60 F 254 plates (Merck). Column chromatography was carried out on Kieselgel 60 (70-230 mesh and 230-400 mesh). All materials and reagents purchased were used without further purification.
Synthesis of a a-Truxillic Acid (1) Compound 1 was prepared according to a previous report. 
7)
Synthesis of a a-Truxillic Acid Dimethylester (3) To a solution of a-truxillic acid (1.0 g, 3.38 mmol) in methyl ethyl ketone (40 ml), trimethylsilyldiazomethane (4 ml) in ether (10 ml) was added dropwise under stirring. After 1 h reaction, the reaction solution was concentrated under reduced pressure, and the residue was purified by column chromatography on silica gel with CHCl 3 Synthesis of 4,4-Dihydroxy-a a-truxillic Acid Dimethylester (4) To a solution of 4,4Ј-dihydroxy-a-truxillic acid (1.0 g, 3.05 mmol) in methyl ethyl ketone (40 ml) and MeOH (20 ml), trimethylsilyldiazomethane (4 ml) in ether (10 ml) was added dropwise under stirring. After 1 h reaction, the reaction solution was concentrated under reduced pressure, and the residue was purified by column chromatography on silica gel with hexane-AcOEt 
Synthesis of a a-Truxillic Acid Bis(p-nitrophenyl)ester (5)
A mixture of a-truxillic acid (435 mg, 1.47 mmol) and thionyl chloride (2.47 g) and N,N-dimethylformamide (one drop) was refluxed for 3 h. After drying, the excess thionyl chloride was removed d: and a-truxillic acid chloride was obtained. To a solution of p-nitrophenol (230 mg) in THF (3 ml) and pyridine (0.5 g), a-truxillic acid chloride (500 mg) in THF (1 ml) was added dropwise at 0-5°C under stirring. After 2 h of stirring, the reaction mixture was poured into water (500 ml) and filtered off. The precipitate was recrystallized from methyl ethyl ketone gave a-truxillic acid bis(p-nitrophenyl)ester (580 mg, 73.4%) as a needle crystal, mp 230-231°C. IR (KBr) cm 
9)
Synthesis of 1,3-Dibenzoyl-2,4-di(4-chlorophenyl)cyclobutane (6) p-Chlorobenzalacetophenone (1.0 g, 4.13 mmol) was treated in a manner similar to the conversion of (E)-cinnamic acid to a-truxillic acid (1). After 2 d irridation, the product was filtered off and recrystallized twice from 45 (2H, m, b, bЈ-H), 4.82 (2H, m, a, aЈ-H 
12)
Synthesis of b b-Truxinic Acid Bis(p-nitrophenyl)ester (10) To a solution of p-nitrophenol (6.0 g, 40.96 mmol) in THF (60 ml) and pyridine (1.9 g), cinnamyl chloride (6.8 g) in THF (2 ml) was added at 0-5°C, and the reaction was stirred at the same temperature for 2 h. The reaction mixture was then poured into water (800 ml) and filtered off to give a precipitate (9.7 g, 88.0%). The dried precipitate (9.0 g, 33.45 mmol) was treated in a manner similar to the conversion of (E)-cinnamic acid to a-truxillic acid (1). After 10 h irridation, the product was filtered off and recrystallized from methyl ethyl ketone to give b-truxinic acid bis(p-nitrophenyl)ester as a needle crystal (6.4 g, 
Formalin Test and Treatments
This method represented a modification of that described by Dubuisson and Dennis. 13) Male ddy mice (25Ϯ5 g) were used. The tested drugs (40 mg/kg) were prepared as suspensions with 0.5% Tween 80/saline and intraperitoneally administered 10 min prior to the injection of an inducer (1.0% formalin/saline, 20 ml). The mice were observed for 30 min, and the time the mice spent licking the injected right hindpaw was recorded. The nociceptive scores normally peaked at 0 to 10 min after formalin injection (early phase) and 10 to 30 min (late phase) after the injection, representing the neurogenic and inflammatory pain responses, respectively.
14) The time spent licking the injected paw was recorded and the data are expressed as total licking time in the early phase and late phase.
Comparison with Indomethacin The tested drugs (0.625, 2.5, 10, 40 mg/kg for 2; 2.5, 10, 40 mg/kg for 6 and 8; 10, 20, 40 mg/kg for indomethacin) were prepared as suspensions with 0.5% Tween 80/saline, and were intraperitoneally administered 10 min prior to the injection of an inducer (2.0% formalin/saline, 20 ml).
Statistical Analysis All values are expressed as meanϮ S.E. (nϭ10). The ED 50 was determined according to the Method of Lichfield and Wilcoxon. 15) For statistical analysis, one-way analysis of variance combined with Dunnett's multiple range test for multiple comparisons were used. Differences were considered significant at pϽ0.01.
RESULTS AND DISCUSSION
The formalin-induced licking response has been used as a model for evaluating new analgesics. 14, 16) The duration of the nociceptive response induced by formalin can be divided into two phases. The early phase is from 0 to 10 min after formalin injection, and the late phase is from 10 to 30 min after the injection. The pain of the early phase is evoked by direct stimulation of the nerve fibers, and that of the late phase is due to the inflammatory reaction. Centrally acting drugs such 582 Vol. 29, No. 3 Table 1 . Comparison of the Activities of 4,4Ј-Dihydroxy-a-truxillic Acid (2), 1,3-Dibenzoyl-2,4-di(4-chlorophenyl)cyclobutane (6) and 4,4Ј-Dichloro-btruxinic Acid (8) In the present study, a-truxillic acid (1) and its derivatives (2-6), as well as b-truxinic acid (7) and its derivatives (8-10) were prepared, and their activities were evaluated in the formalin test. All compounds were tested intraperitoneally for their activities at the dose of 40 mg/kg body weight by formalin test, and the results are summarized in Fig. 2 . All compounds showed only weak or no activity against the neurogenic pain response (early phase), but exhibited significant activity against the inflammatory pain response (late phase) induced by formalin. The highest anti-inflammatory activities were observed for a-truxillic acid (1) and its derivative 4,4Ј-dihydroxy-a-truxillic acid (2) . In addition, 4,4Ј-dichlorolated derivatives 1,3-dibenzoyl-2,4-di(4-chlorophenyl)cyclobutane (6) and 4,4Ј-dichloro-b-truxinic acid (8) also showed strong anti-inflammatory activities. a-Truxillic acid (1) and its derivative a-truxillic acid bis(p-nitrophenyl)ester (5) had higher anti-inflammatory activities than b-truxinic acid (7) and the corresponding derivative (10) . Free carboxylic acids (1, 2) showed higher activities than their dimethyl esters (3,  4) . The anti-inflammatory activity of a-truxillic acid bis(pnitrophenyl)ester (5) was weaker than that of a-truxillic acid (1), but the activity of b-truxinic acid bis(p-nitrophenyl)ester (10) was equal to that of b-truxinic acid (7). 4,4Ј-Dichloro-btruxinic acid (8) had higher activity than its parent compound b-truxinic acid (7).
We then compared the anti-inflammatory activities of 4,4Ј-dihydroxy-a-truxillic acid (2) , which showed the highest anti-inflammatory activity, and two 4,4Ј-dichlorolated derivatives (6, 8) which also showed strong activities, with that of indomethacin (a nonsteroidal anti-inflammatory drug) in the formalin test, with a higher concentration formalin (2.0%, 20 ml) as an inducer. All compounds exerted only weak or no activity against the neurogenic pain response (early phase), but produced marked and dose-related inhibition of the formalin-induced inflammatory pain response (late phase). The anti-inflammatory activities of 2, 6 and 8 were stronger than that of indomethacin. The ED 50 values for 2, 6 and 8 were 4.93, 11.2 and 24.9 mmol/kg respectively, while the value for indomethacin was 117.0 mmol/kg (Table 1, Fig. 3 ). The activities of 2, 6 and 8 were about 5-to 24-fold more potent than that of indomethacin. These results suggested that 2, 6 and 8 possess very strong anti-inflammatory activity, and a-truxillic acid and b-truxinic acid derivatives might be developed into a new type of anti-inflammatory drug.
In conclusion, these results clearly indicated that a-truxillic acid and b-truxinic acid derivatives are another group of leading compounds important for developing a new type of anti-inflammatory drug. The result also supported that the dimeric structure played an important role in the expression of anti-inflammatory activity. Further investigation is required to develop more potent anti-inflammatory derivatives and to elucidate the precise mechanism underlying these activities. 
